An explorative, nonrandomized, openlabel, inclinic study investigating the performance of a novel noninvasive glucose monitoring device using a new guided calibration method (RSP-26)

Aim of the study

Performance assessment of a guided calibration approach for the P0.5 prototype, using venous and capillary glucose reference values.

‍

Study description

Participants completed two intensive inclinic study days involving frequent device measurements, taken independently or paired with capillary and venous glucose references. The study evaluated a new guided calibration method and assessed whether a reduced calibration scheme could still deliver strong predictive performance. All participants were enrolled into the venoussampling subprotocol following interim analysis.

‍

Conclusions

‍A guided calibration approach achieved strong accuracy with substantially fewer calibration measurements, supporting more practical future use.

‍

Related peer-reviewed publication

‍Pors A, Korzeniowska B, Rasmussen MT, Lorenzen CV, Rasmussen KG, Inglev R, Philipps A, Zschornack E, Freckmann G, Weber A, Hepp KD. Calibration and performance of a Raman-based device for non-invasive glucose monitoring in type 2 diabetes. Sci Rep. 2025 Mar 25;15(1):10226. doi: https://doi.org/10.1038/s41598-025-95334-x  

‍

Study registration

‍For more information, see the study registration on ClinicalTrials.gov (NCT05851469).

About the study

Prototype ID: P0.5

Comparator: Contour Next One (BGM); Cobas venous analyzer

Site: Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH, Ulm University, Germany

No of participants: 50

Profile of participants: Adults (≥18 years) with type 2 diabetes

Study period: May 2023 to July 2023

Study days:

  • Day 1: 24 measurements over ~9 hours
  • Day 2: 26 measurements over ~9.5 hours